USNA צמיחה צפויה ברווח נקי למניה השנה USANA Corp

The high resilience of USANA Health Sciences (USNA) cash flows makes the asset attractive, as confirmed by the relative change in EPS compared to the same period last year; the value of -71.40 reflects this status. Revenues are based on the sale of nutraceuticals through independent partners. Meanwhile, the company is mitigating its dependence on the Asia-Pacific region by expanding its range of skincare products.
פילוחי מדדים מקיפים ואנליטיקה עבור USANA (USNA)

The year-over-year net income per share dynamics for USANA Health Sciences (USNA) determine capital allocation efficiency and the pace of profit scaling for shareholders. This calculation allows for an assessment of how effectively the stable cash flow from regular nutraceutical purchases converts into real yield growth, which is clearly reflected in the annual earnings per share growth.